AI-driven chart review accurately identifies potential rare disease trial participants in new study
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Apr-2026 14:16 ET (2-Apr-2026 18:16 GMT/UTC)
Newly published research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) to identify patients who are eligible for a rare disease clinical trial.
Published in The Journal of Cardiac Failure, the official journal of the Heart Failure Society of America, the study offers real-world evidence that artificial intelligence (AI)-enabled medical chart review can improve the speed, accuracy and equity of trial enrollment.
By converting plastic waste into a microbe-friendly food source, scientists have built an upcycling pipeline that turns the waste into a variety of useful products.